Zulueta, Norfaida .

HRN: 19-17-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2026
CO-AMOXICLAV 625MG (TAB)
04/21/2026
04/28/2026
ORAL
625mg
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: